Correlation Between Marizyme and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Marizyme and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marizyme and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marizyme and Aerovate Therapeutics, you can compare the effects of market volatilities on Marizyme and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marizyme with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marizyme and Aerovate Therapeutics.
Diversification Opportunities for Marizyme and Aerovate Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Marizyme and Aerovate is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Marizyme and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Marizyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marizyme are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Marizyme i.e., Marizyme and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Marizyme and Aerovate Therapeutics
Given the investment horizon of 90 days Marizyme is expected to generate 3.06 times more return on investment than Aerovate Therapeutics. However, Marizyme is 3.06 times more volatile than Aerovate Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 91.00 in Marizyme on September 3, 2024 and sell it today you would lose (86.00) from holding Marizyme or give up 94.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Marizyme vs. Aerovate Therapeutics
Performance |
| Timeline |
| Marizyme |
| Aerovate Therapeutics |
Marizyme and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Marizyme and Aerovate Therapeutics
The main advantage of trading using opposite Marizyme and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marizyme position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Marizyme vs. NRx Pharmaceuticals | Marizyme vs. RenovaCare | Marizyme vs. Aerovate Therapeutics | Marizyme vs. Akari Therapeutics PLC |
| Aerovate Therapeutics vs. DiaMedica Therapeutics | Aerovate Therapeutics vs. Lyra Therapeutics | Aerovate Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |